158 related articles for article (PubMed ID: 26498527)
1. Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD(+) metabolism.
Pandit A; Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwon KB; Kwak TH; Choe SK; Park R; So HS
Biochem Biophys Res Commun; 2015 Nov; 467(4):697-703. PubMed ID: 26498527
[TBL] [Abstract][Full Text] [Related]
2. Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.
Kim HJ; Pandit A; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwak TH; Choe SK; Park R; So HS
Hear Res; 2016 Mar; 333():235-246. PubMed ID: 26341473
[TBL] [Abstract][Full Text] [Related]
3. Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD
Nazari Soltan Ahmad S; Rashtchizadeh N; Argani H; Roshangar L; Ghorbani Haghjo A; Sanajou D; Panah F; Ashrafi Jigheh Z; Dastmalchi S; Mesgari-Abbasi M
Free Radic Res; 2018 Jul; 52(7):808-817. PubMed ID: 29865885
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of NAD
Khadka D; Kim HJ; Oh GS; Shen A; Lee S; Lee SB; Sharma S; Kim SY; Pandit A; Choe SK; Kwak TH; Yang SH; Sim H; Eom GH; Park R; So HS
J Mol Cell Cardiol; 2018 Nov; 124():45-57. PubMed ID: 30291911
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.
Kim HJ; Oh GS; Shen A; Lee SB; Choe SK; Kwon KB; Lee S; Seo KS; Kwak TH; Park R; So HS
Cell Death Dis; 2014 Jun; 5(6):e1292. PubMed ID: 24922076
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice.
Oh GS; Kim HJ; Choi JH; Shen A; Choe SK; Karna A; Lee SH; Jo HJ; Yang SH; Kwak TH; Lee CH; Park R; So HS
Kidney Int; 2014 Mar; 85(3):547-60. PubMed ID: 24025646
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase-1-induced NAD(+) depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation.
Kauppinen TM; Gan L; Swanson RA
Biochim Biophys Acta; 2013 Aug; 1833(8):1985-91. PubMed ID: 23597856
[TBL] [Abstract][Full Text] [Related]
8. Cellular NAD depletion and decline of SIRT1 activity play critical roles in PARP-1-mediated acute epileptic neuronal death in vitro.
Wang S; Yang X; Lin Y; Qiu X; Li H; Zhao X; Cao L; Liu X; Pang Y; Wang X; Chi Z
Brain Res; 2013 Oct; 1535():14-23. PubMed ID: 23994215
[TBL] [Abstract][Full Text] [Related]
9. PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity.
Caito S; Hwang JW; Chung S; Yao H; Sundar IK; Rahman I
Biochem Biophys Res Commun; 2010 Feb; 392(3):264-70. PubMed ID: 20060806
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells.
Jung YJ; Lee JE; Lee AS; Kang KP; Lee S; Park SK; Lee SY; Han MK; Kim DH; Kim W
Biochem Biophys Res Commun; 2012 Mar; 419(2):206-10. PubMed ID: 22330808
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Cellular NAD
Cao W; Zhu MY; Lee SH; Lee SB; Kim HJ; Park BO; Yoon CH; Khadka D; Oh GS; Shim H; Kwak TH; So HS
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769515
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity.
Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Pandit A; Shim H; Yang SH; Cho EY; Song J; Kwak TH; Choe SK; Park R; So HS
Hear Res; 2015 Aug; 326():30-9. PubMed ID: 25891352
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity.
Kim J; Long KE; Tang K; Padanilam BJ
Kidney Int; 2012 Jul; 82(2):193-203. PubMed ID: 22437413
[TBL] [Abstract][Full Text] [Related]
14. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats.
Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Poljak A; Grant R
PLoS One; 2011 Apr; 6(4):e19194. PubMed ID: 21541336
[TBL] [Abstract][Full Text] [Related]
15. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.
Bai P; Cantó C; Oudart H; Brunyánszki A; Cen Y; Thomas C; Yamamoto H; Huber A; Kiss B; Houtkooper RH; Schoonjans K; Schreiber V; Sauve AA; Menissier-de Murcia J; Auwerx J
Cell Metab; 2011 Apr; 13(4):461-468. PubMed ID: 21459330
[TBL] [Abstract][Full Text] [Related]
16. New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity.
Oh GS; Kim HJ; Shen A; Lee SB; Yang SH; Shim H; Cho EY; Kwon KB; Kwak TH; So HS
Biomed Res Int; 2016; 2016():4048390. PubMed ID: 26881219
[TBL] [Abstract][Full Text] [Related]
17. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
18. NAD+ as a metabolic link between DNA damage and cell death.
Ying W; Alano CC; Garnier P; Swanson RA
J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
[TBL] [Abstract][Full Text] [Related]
19. Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity.
Gang GT; Kim YH; Noh JR; Kim KS; Jung JY; Shong M; Hwang JH; Lee CH
Toxicol Lett; 2013 Aug; 221(3):165-75. PubMed ID: 23831944
[TBL] [Abstract][Full Text] [Related]
20. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
